Blood transfusion after on-pump coronary artery bypass grafting: focus on modifiable risk factors

Luca Salvatore De Santo1, Cristiano Amarelli, Alessandro Della Corte

  • 1Chair of Cardiac Surgery, University of Foggia, Foggia, Italy. luca.desanto@ospedalemonaldi.it

Insights

Perioperative transfusions increase risks after coronary artery bypass grafting (CABG). Identifying high-risk patients and managing transfusion exposure can improve outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Critical Care Medicine

Background:

  • Perioperative transfusions are associated with increased morbidity and mortality following coronary artery bypass grafting (CABG).
  • Identifying patients at highest risk from transfusions is crucial for improving surgical outcomes.

Purpose of the Study:

  • To identify the clinical profile of patients at highest risk from perioperative transfusions during CABG.
  • To determine the causative relationship and dose-dependency of blood transfusions on hospital mortality.

Main Methods:

  • Prospective observational study of 1047 consecutive patients undergoing on-pump isolated CABG.
  • Utilized univariate and multivariate regression analysis, propensity scoring, and binary segmentation for risk stratification.
  • Analyzed risk factors including age, body surface area, preoperative hemoglobin, surgical priority, cardiopulmonary bypass duration, and blood loss.

Main Results:

  • Independent risk factors for transfusion included age, body surface area, preoperative glomerular filtration rate, preoperative hemoglobin, surgical priority, cardiopulmonary bypass duration, intraoperative hemodilution, and postoperative blood loss.
  • Patients with body surface area < 1.73, preoperative hemoglobin < 12 g/dl, intraoperative hemoglobin < 8.0 g/dl, and cardiopulmonary bypass > 90 minutes were at higher risk.
  • A dose-dependent relationship was observed, with patients receiving more than 5 units of blood products exhibiting the highest risk of mortality.

Conclusions:

  • Preoperative patient stratification and tailored management strategies can help prevent high exposure to blood transfusions.
  • Optimizing surgical timing and cardiopulmonary bypass techniques are key to minimizing transfusion needs and improving patient safety.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...